[1]杨丹,洪莉*.宫颈小细胞癌的临床病理分析[J].中国计划生育和妇产科,2016,(6):46- 50,55.
　YANG Dan,HONG Li*.Clinicopathological study of small cell carcinoma of the cervix[J].Chinese Journal of Family Planning & Gynecotokology,2016,(6):46- 50,55.
点击复制

宫颈小细胞癌的临床病理分析
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2016年6期
页码:
46- 50,55
栏目:
论著与临床
出版日期:
2016-06-25

文章信息/Info

Title:
Clinicopathological study of small cell carcinoma of the cervix
作者:
杨丹; 洪莉*
武汉大学人民医院妇产科
Author(s):
YANG Dan ; HONG Li*
Department of Gynecology and Obstetrics, People’s Hospital of Wuhan University,Wuhan Hubei 430060,P.R.China
关键词:
宫颈小细胞癌; 病理特点; 治疗; 预后
Keywords:
SCCC;  pathological characteristics;  treatment;  prognosis
分类号:
R 737.33
摘要:
目的探讨宫颈小细胞癌（small cell carcinoma of cervix, SCCC）的临床病理特点，分析治疗效果及预后。方法回顾性分析2009年1月至2015年3月武汉大学人民医院收治的原发性SCCC患者的临床及病理资料，分析治疗方法的选择及预后。结果13例SCCC占我院同期收治的所有宫颈癌的06 %。根据国际妇产科联合会2014标准进行分期：Ⅰ B1期2例，Ⅰ B2期5例，Ⅱ A1期2例，Ⅱ A2期3例，Ⅳ A期1例。将13例患者根据临床分期的不同分别行新辅助化疗、根治术、术后化疗、同步放化疗等综合治疗。截止2015年3月，平均随访时间为386个月，患者中4例死亡，9例无瘤生存。结论 SCCC发病罕见，主要以病理学诊断为主，结合免疫组化染色提高准确率。临床分期Ⅰ期者预后较好，Ⅱ期及以上者进展迅速，恶性程度高，容易发生远处转移。故应对患者进行早期诊断及选择个性化的治疗方式，改善预后提高生存率。
Abstract:
ObjectiveTo explore the clinicopathologic characteristics of small cell carcinoma of the cervix(SCCC) and analyze the therapeutic effects and prognosis. MethodsThe clinical and pathological data which diagnosed as SCCC in People’s Hospital of Wuhan University from January 2009 to March 2015 were collected and followed up. To analyze the treatment method and prognosis of SCCC. ResultsThe incidence of 13 cases of SCCC accounts for about 0.6 % in all cervical cancer during the same period in our hospital. 13 cases of SCCC were staged according to the standard of and obsterics(international federation of gyncology and obstetrics, FIGO) 2014: Ⅰb1 stage 2 cases, Ⅰb2 stage 5 cases, Ⅱa1 stage 2 cases, Ⅱa2 stage 3 cases, Ⅳa stage 1 case. Comprehensive treatment including neoadjuvant chemotherapy, radical operation, postoperative chemotherapy, concurrent radiochemotherapy were adopted respectively for 13 patients according to different clinical stages. The average follow-up time was 38.6 months. By March 2015, 4 cases died, 9 cases of disease-free survival. ConclusionSCCC is a rare tumour, and the diagnosis mainly depends on pathological examination which combining with immunohistochemical staining to improve diagnostic accuracy. The prognosis of stage I is well, however phase II and above which has high malignant degree and prone to distant metastases progresses rapidly. So early diagnosis and personalized treatment method can improve the survival rate.

参考文献/References:

［1］BIFULCO G, MANDATO V D, GIAMPAOLINO P, et al. Small cell neuro-endocrinecervical carcinoma with I-year follow-up:case report and review［J］. Anticancer Research, 2009, 29(2): 477-484. ［2］张志毅，章文华．现代妇科肿瘤外科学［M］．北京：科学技术出版社，2003：240-241． ［3］CROWDER S, TULLER E. Small cell carcinom of the female genital tract［J］. Seminars in Oncology, 2007, 34(1): 57-63. ［4］SHIN S J, DELELLIS R A, YING L, et al. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients［J］. The American Journal of Surgical Pathology, 2000, 24(9): 1231-1238. ［5］孙霞，胡文静，任伟，等．宫颈小细胞癌乳腺转移临床分析［J］．现代肿瘤医学，2014，22（1）：183-184． ［6］WANG K L, CHANG Ting-chang, JUNG S M, et al. Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese Gynecologic Oncology Group study［J］. European Journal of Cancer (Oxford, England : 1990), 2012, 48(10): 1484-1494. ［7］HORN L C, LINDER K, SZEPANKIEWICZ G, et al. p16,p14,p53 and cyclin DI expression and HPV analysis in small cell carcinomas of the uterine cervix［J］. International Journal of Gynecological Pathology, 2006, 25(2): 182-186. ［8］MASUMOTO N, FUJII T, ISHIKAWA M, et al. p16 overex-oression and human papillomavirus infection in small cell carcinoma of the uterine cervix［J］. Human Pathology, 2003, 34(8): 778-783. ［9］HERRINGTON C S, GRAHAM D, SOUTHERN S A, et al. Loss of retinoblastoma protein expression in frequent in small call neuroendocrine carcinoma of the cervix and is unrelated to HPV type［J］. Human Pathology, 1999, 30(8): 906-910. ［10］TSUNODA S, JOBO T, ARAI M, et al. Small-cell carcinoma of the uterine cervix:a clinicopathological study of 11 cases［J］. International Journal of Gynecological Cancer, 2005, 15(2): 295-300. ［11］祝洪澜，王建六，鲍冬梅，等．宫颈小细胞癌6例临床病理分析［J］．中国妇产科临床杂志，2010，11（2）：101-104． ［12］美丽帕，程静新．宫颈小细胞癌13例临床分析［J］．中国社区医师（医学专业），2012，13（13）：165-166． ［13］李荣岗，陈兰花，孙丽霞，等．26例子宫颈小细胞癌临床病理特征及预后分析［J］．中国当代医药，2015，22（9）：107-110． ［14］王子毅，吴令英，姚洪文，等．早期子宫颈神经内分泌癌32例临床分析［J］．中华妇产科杂志，2015，50（3）：198-203． ［15］COHEN J G, KAPP D S, SHIN J Y, et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients［J］. American Journal of Obstetrics and Gynecology, 2010, 203(4): 347.e1-347.e6. ［16］YUAN Lei, JIANG Hong-yuan, LU Yin, et al. Prognostic factors of surgically treated Early-Stage small cell neuroendocrine carcinoma of the cervix［J］. International Journal of Gynecological Cancer, 2015, 25(7): 1315-1321. ［17］LI Xiong, YANG Ru, JIA Yao, et al. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy［J］. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 2015, 130(1): 31-35.

相似文献/References:

[1]杨开选.子宫平滑肌瘤的病理[J].中国计划生育和妇产科,2012,(03):0.
　YANG Kai - xuan.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(6):0.
[2]于晓兰.剖宫产瘢痕妊娠的病理特点[J].中国计划生育和妇产科,2013,(04):0.
　YU Xiao-lan.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[3]杨丹,洪莉.宫颈小细胞癌的临床病理分析[J].中国计划生育和妇产科,2016,(06):0.
　YANG Dan,HONG Li,[J].Chinese Journal of Family Planning & Gynecotokology,2016,(6):0.

更新日期/Last Update: 1900-01-01